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Robotic Manipulator for Positioning a Magnetic Actuator Dedicated to Drug
Delivery in the Cochlea
Manel Abbes1,2, Karim Belharet3, Mouna Souissi3, Hassen Mekki1 and Gérard Poisson2
Abstract— The actuators dedicated to micrometric applica-
tions are known for their precision but also for their restricted
workspace. The use of a robotic manipulator as a carrier makes
it possible to considerably increase this workspace. In this
paper, we present a novel robotic system specially designed for
positioning a magnetic actuator based on permanent magnets,
used as an end-effector of the robot for steering magnetic
microrobot throughout the cochlea. Using the classical mathe-
matical tools of serial robotics, we determined the direct and
inverse kinematic models of the manipulator, thus defining a
reference trajectory to move the microrobot on a space as small
as possible and take account of the geometrical specifications
based on medical needs. A prototype has been realized with a
3D printer to experimentally validate the numerical results. In
addition, the mechanical considerations for the construction of
the prototype are presented.
Index Terms— Inner ear drug delivery, Cochlea, Medical
robotics, Robotic manipulator, RCM Mechanisms, Magnetic
actuator, Microrobot.
I. INTRODUCTION
The conventional routes of administration to the inner ear,
such as oral or parenteral routes are largely ineffective princi-
pally because the blood-perilymph barrier isolates this organ
from the blood [1]–[3]. Indeed, the extreme inaccessibility
of the cochlea and its very small volume, makes the inner
ear one of the most challenging target organs for local drug
delivery [4]–[7].
In fact, the ear is composed of three parts: external, middle
and inner ear. The inner ear, which contains both the organ
of hearing (cochlea) and the organ of balance (vestibular
system).
The cochlea is the organ where acoustic signals are
transformed into neural pulses which are then signaled to
the brain. The two human cochleae are mirror-shaped, fluid
filled, coiled, fairly symmetrical bony tubes situated in the
petrous pyramids of the temporal bones. Perilymph; the fluid
inside the scalae vestibuli and tympani communicates with
the cerebrospinal fluid (CSF) via the cochlear aqueduct. This
route of fluid communication can allow spread of infections
between these fluid compartments such as Vestibular neuritis,
Labyrinthitis, Meniere’s disease, Vestibular migraine and
Conductive hearing loss. Accessing the inner ear has always
been a tough mission as it is well protected by the presence
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of the blood-cochlear barrier. Therefore, researches have
continuously evolved in order to find out new strategies
for treating and restoring hearing loss. There are two main
techniques for delivering a therapeutic agent to the inner
ear. The first method is Intracochlear administration that
consists on dipositing drugs in the perilymphatic spaces of
the cochlea. This method offers a great potential for the
control with no dependence on the permeability of the round
window membrane. It permits drugs to directly reach the
inner ear’s cells by passing through the middle ear. But, there
are risks of a total hearing loss caused by high hydrostatic
pressure. The second method is Intratympanic administration
that is an old one but commonly used technique for treating
inner ear diseases. It consists on placing drugs in the middle
ear, then this therapeutic agent accesses the inner ear through
the round window membrane which is permeable to many
drugs. But there are concerns about the health of the patient
as there is a risk of toxicity, also a poor diffusion in the
cochlea or a massive leakage through the eustachian tube
are possible. The Hydrogel-based intratympanic delivery
consists on loading drugs into the hydrogel matrix thanks
to the extremely porous structure of the hydrogel. Then,
once instilled into the middle ear, hydrogel releases drug in
a controlled way. However, it is a long-lasting technique,
it is not easy to remove the gel’s agents and there are
risks of poor diffusion in the superior areas of the cochlea.
The administration via magnetic nanoparticles represents a
promising and challenging new avenue for controlled drug
delivery to the inner ear. Nanoparticles have a considerable
capacity to easily cross the round window membrane offering
an intended delivery of drugs to targeted cells in the cochlea.
This technique lasts for a short period of time and allows
the diffusion of drugs in all regions of the cochlea without
causing any damage to the round window membrane when
a specific magnetic system for inner ear drug deliver is
used. We have proposed a magnetic prototyping platform
for drug delivery in the inner ear using magnetic particles.
This platform is composed of a magnetic actuator based
on permanent magnets [8], a tracking vision system and a
robotic manipulator.
In this paper we propose a novel robotic system for
positioning a magnetic actuator based on permanent magnets.
Section (II) presents the anatomy of the cochlea and the
operating principle of the magnetic actuator. This represents
the constraints to be considered in the design of the robotic
manipulator. Section (III) describes the direct and inverse
kinematic models of the proposed robot. Section (IV) shows
the simulation results to validate the robotic structure. Fi-
nally, section (V) depicts the realized prototype with a 3D
printer. The paper is concluded in section (VI).
II. SYSTEM REQUIREMENTS
A. Clinical procedure of targeted drug delivery in the inner
ear
Targeted drug delivery in inner ear is a non-invasive
method which allows to steer magnetic particles to targeted
cells in the ear. This operation is performed in several steps
and lasts for around 30 minutes. Before all, the patient lies on
the operating table with a specific position of the head, using
a fixing tool. Several markers are fixed on the patient’s head
and used to correct the robot’s motion. Then a Magnetic
Resonance Imaging (MRI) scan is realized to locate the
cochlea and extract its position, in the 3D space, relative
to the markers’ frame. After that, the patient is moved to
the operating room where the drug delivery procedure will
be performed. A tracking vision system is developed and
used to compensate any possible motions of the patient’s
head. Indeed, it uses the markers frame in order to define
the cochlea’s position relative to the cameras frame. Once the
head moves, the vision system calculates the new position
of the cochlea and sends it to the robot controller in order
to redefine the trajectory. In addition, a magnetic actuator
is used to steer the magnetic particles inside the cochlea.
The later is developed, in our laboratory, specifically for
targeted drug delivery and has a specific operating mode.
The actuator’s axis has to be aligned with the direction of
the particle displacement in order to be able to push or pull
particles in this direction. Therefore, to perform the different
directions, we need to move the actuator around the head in
the 3D space. This requires the use of a robotic manipulator,
adapted to the sphericity of the workspace and the constraints
related to the cochleas anatomy and the magnetic actuator.
B. Anatomical constraints
The cochlea as it can be viewed in Fig.1 is a set of
membranous tubes, 31−33mm in human. This tube is coiled
much like a snail shell to form 2 and a half turns around
its axis [9]. There are two orifices in the surface of the
cochlear bone, both of which are located at the base of the
cochlea. The round window is a membranous opening in
the bone within the scala tympani and the oval window,
in the scala vestibuli. Perilymph is the primary fluid of
the cochlea and its volume in the human cochlea is about
70µL. The height of the bony cochlea is approximately
4mm and the width of its basal coil, which is the largest,
is about 7mm (see Fig.1). We note also the presence of
a slight inclination between turns, approximately 9 degrees
between the basal and the middle turn and about 2.4 degrees
between the middle and the spacial turn [10]. Moreover,
the spatial cochlea’s orientation in the skull is defined in
[11]. The modiolar axis of the cochlea makes an average
angle (A) of about 40 degrees with the Midsagittal plane.
Also, the cochlea axis is almost horizontal since that the
lateral semicircular canal (LSC) forms 30 degrees forward
and upward to the skull’s horizontal plane [12].
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Fig. 1. Geometrical characteristics of the cochlea: (a) Cochlear channel
(b) Cochlea’s position
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Fig. 2. Magnetic actuator and the magnetic gradient generated
C. Actuator constraints
The location of the inner ear and the anatomical obstacles
such as the head, make pulling the particles by an external
magnet not optimal and neither possible. Indeed to pull
a particle into the inner ear, the pulling magnet must be
placed on the opposite side of the head at a long working
distance. Unlike the systems that use a single permanent
magnet, a motorized device that combines two permanent
magnets has been developed for this application (see Fig.2)
and has demonstrated its ability to create both push and pull
forces [8]. The area between the pushing and the attractive
forces has canceled forces that are called Lagrangian points.
The actuator creates five Lagrangian points but only one
of them is stable and allows to fix the microrobot in a
targeted position, which is the Lagrangian point L2. Once
we change inclination between the two permenant magnets,
the magnetic fields’ configuration and so the position of
the Lagrangian points are modified. As shown in Fig.2 the
push and pull forces are created over an interval of about
5mm called actuating band. Any particle positioned in this
band can be either pushed or pulled according to its position
relative to the Lagrangian point L2. To guide a magnetic
particle on the helical path of the cochlea, the actuator must
rotate with respect to the revolution axis of the cochlea (see
Fig.1). The strategy adopted, to drive the nanoparticules to
the cochlea’s apex, is to firstly divide the cochlea into linear
segments. Then, a robotic manipulator moves the actuator
until the superposition of the actuator’s x-axis and the desired
segment to push or pull microrobot inside the cochlea.
D. Safety constraints
Alike new collaborative robots in industry, medical ones
are designed to act in proximity of patients. Therefore, there
are many concerns about safety, sterilization and accuracy.
Since the application is not invasive we do not have to deal
with sterilization issues. Safety is a critical concern because
the manipulator is designed to act in a fully automatic mode.
The patient’s head must be fixed in a definite position in
order to define the robot’s workspace and guarantee that
no interference with the patient is possible in any case
while keeping a minimal safety distance of 2cm between
the magnetic actuator and the patient’s head. Moreover, it
is necessary to privilege a system with mechanical stops
in addition to the software ones (software programmable
workspace limitations). Finally, since the patient will not be
anesthetized during the process of targeted drugs administra-
tion, potential movements of the head have to be considered.
For this reason, the robot uses informations received from the
vision system to compensate those movements.
The characterization and specification of the medical needs
and different constraints allow us to choose functional and
technological specifications of the robotic system. The first
step consists of choosing the kinematic architecture. In the
next section, we propose the kinematics modeling of the
novel manipulator that fulfills the previous constraints.
III. MODELING AND MECHANICAL DESIGN OF THE
MANIPULATOR
A. Medical robots state of art
To validate drug delivery strategy, preliminary experiences
had been realized using a 6 degree of freedom (DOF) serial
manipulator, the FANUC LR Mate 200iD robot. However,
some positions are not reachable because of the limitations
of its workspace [13]. Moreover, there are several concerns
about the safety of the patient with this type of robots, as
there is a potential risk of collision between the robotic ma-
nipulator and the patient. The desired kinematic architecture
must allow 3D guidance of the magnetic actuator around
the patient’s head, by realizing a spherical movement whose
center of rotation is the center of the cochlea (away from
the structure). This need of kinematic structure with a fixed
point is common for several medical robots, and is called
Remote Center of Motion (RCM) mechanism. The latter can
be achieved mechanically or virtually. However for clinical
applications, mechanical RCM systems are more favorable
due to their reliability, rigidity and easy control systems
which make them more safe. These mechanisms are well
classified and systemized in [14].
A parallel system was implemented in a vitreoretinal
surgery robot [15]. With 6-DOF this robot is capable of
performing high positioning accuracy within the eye. A
double parallelogram structure was also used for minimally
invasive surgery, it is a 7-DOF mechanism that fulfills the
incision point constraints and provides a high degree of
dexterity [16]. Although the simplicity of these parallel
structures and the large movement range that they can offer,
they present many singularities and lack rigidity because of
their numerous revolute joints.
Another commonly used mechanism is the spherical one
which is suggested for several clinical applications. A needle
guidance system for MRI-guided liver interventions was
presented in [17]. It is a compact device with 2-DOF that
allows angling the needle at the skin entry using a double
ring RCM mechanism. Also a spherical serial mechanism
(IRISS), able to perform many intraocular surgical steps with
high accuracy, was introduced in [18]. A serial robotic device
with 7-DOF, was developed and commercialized by Axilum
Robotics for Transcranial Magnetic Stimulation (TMS) [19].
The latter used two spherical mechanisms to adapt the
workspace’s shape which is almost a sphere centered on the
patient’s head.
Despite the fact that spherical mechanisms supply exact
spherical motion at the fixed point, a defined number of
DOF as well as a specific alignment of the joints are needed
to perform the drug delivery to the inner ear procedure.
Moreover, there is a need of a specific workspace adapted
to the actuator dimensions; an architecture dedicated to this
task that minimizes the ratio between accessible and useful
workspace by taking advantage of the geometry of the work
area. In view of all the above, the development of a novel
robotic manipulator dedicated to inner ear drug delivery is
clearly necessary.
The challenge in the conception of medical robots is
to design more precise, lighter, less energy-consuming and
more compact structures. To achieve this goal, it is important
to optimize the robot structure, the links shape and the
position of the actuators.
B. Description of the manipulator
In this subsection we present a new mechanism to position
a magnetic actuator around the patient’s head. A RCM
mechanism is adopted to guarantee safety and avoid any risks
of collision between the robot and the patient. We used an
arc guide mechanism to restrict the motion and make sure
that no interference with the patient is possible in any case
[20]. The architecture conceivable for the choice of the serial
bearer is consisting of two segments of circular shape each
having an arc length of 90◦ as shown in Fig.3. The first arc
connects J1 and J2 and the second arc carries the magnetic
actuator (Fig.4).
This mechanism is equivalent to a serial spherical system.
It can be represented by three revolute joints with concurrent
axes (Fig.4) J1,J2 and J3. The three joints are intersected
in the center of cochlea. 3 DOF are sufficient to realize all
the needed displacements, around the patient’s head, while
respecting the constraints mentioned previously. Moreover,
the spherical architecture offers a light weight and a high
precision.
C. Kinematic and inverse kinematic models
The mechanism motion is computed using the Euler an-
gles. The rotated system is specified as follows: first rotation
about Z-axis by an angle ψ (precession), then about X-axis
Fig. 3. The mechanism designed with Solidworks software
Fig. 4. Mechanism’s Kinematics
by an angle θ (nutation) and finally about Z-axis by an angle
φ (own rotation). Thus, a Z-X-Z scheme. For the mechanism,
ψ corresponds to the joint J1, θ corresponds to the joint J2
and φ corresponds to the joint J3 (see Fig.5).
The transformation matrix RT is defined as a sequence of
three rotations:
RT = R(Z,ψ)R(X, θ)R(Z, φ) (1)
The result of multiplication gives:
RT =



Xx Yx Zx
Xy Yy Zy
Xz Yz Zz



On another hand, Euler angles can be identified from the
terms of the transformation matrix, which is well known in
Euler formalism.
ψ = atan2(−Zy, Zx) (2)
θ = arcsin(
√
X2z + Y
2
z ) (3)
φ = atan2(Yz, Xz) (4)
The angle axis representation defines the orientation of
two coordinate frames as a rotation of an angle α around an
axis k. The angle axis α is given by:
α = arccos(
Xx + Yy + Zz − 1
2
) (5)
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Fig. 5. Euler Angles with ’Z-X-Z’ formalism
And the axis k is given by:
k =
1
2 sinα



Xx − Yx
Xy − Yy
Xz − Yz



(6)
This presentation of the angle axis encounters a singular
configuration for α = 0◦ and α = π. For α = 0◦ it can
have any direction, for α = π it can point in two opposite
directions. The singular configurations of such mechanism
are obtained when it is completely folded, or completely
stretched.
The angular velocity in body coordinates can be expressed
as the time derivative of the Euler angles.
IV. SIMULATION AND RESULTS
A. Planning trajectory of the manipulator
The objective is to determine the magnetic actuator coordi-
nates (x,y,z) that allows it to reach the given orientation. The
complete simulation chain, starting from the calculation of
the command angles in Matlab-Simulink until the execution
of the motion in Adams.
The process consists in injecting a series of effector
orientations in the inverse kinematic model and studying
the actuator coordinates. The three orientations correspond
to the precession, nutation and own rotation joints. For
our application the orientation of the magnetic actuator is
given. Using the inverse kinematic model, the position of
the actuator is calculated by the angle axis. The coordinates
of the actuator are given in the Tab.I.
Case Orientation (J1, J2, J3) Position (x,y,z)
1 (0 , 12 , -50) (241.86 , 205.77 , -46.67)
2 (0 , -12 , -50) (242.62 , 207.82 , 53.2)
3 (90 , -24 ,-80) (292.62 , 130.17 , 56.43)
4 (90 , -57 , -80) (147.3 , 268.17 , 56.8)
5 (90 , -50 , -68) (193.8 , 231.2 , 121.7)
TABLE I
POSITIONS AND ORIENTATIONS OF THE MAGNETIC ACTUATOR.
The work area is determined by the positions of the
magnetic actuator relative to the cochlea. There are five
positions to reach with the manipulator in order to steer drugs
Case 1 Case 2
Case 3 Case 4
Case 5
Fig. 6. The five positions of the magnetic actuator.
(s) (s)
Fig. 7. Motions and displacement of magnetic actuator
throughout the cochlea. The five cases are presented in the
Tab.I.
To reach the different cases, we control the three joints
and determine the position of the magnetic actuator. These
simulations permit to fix the application’s work area and limit
the angle of orientation of the three joints.
The joints’ stops are deliberately limited to ±90◦, in order
to take into account collisions with the patient and to reach
all points of the work area. The first joint J1 is limited to
±90◦. Second joint J2 is comprised between 12
◦ and −57◦.
Third joint, the displacement of the magnetic actuator can
take three values −50◦, −80◦ and −68◦. The five cases
of magnetic actuator are simulated with Adams in Fig.6.
Respecting the different constraints, the manipulator can
reach all the desired positions.
Angular velocities applied to the motors are the inputs
of the system in order to check the dynamic behavior of
the manipulator and calculate the magnitude of torques and
forces of translator and rotational motors. Fig.7 shows the
trajectories of the three joints and the displacement of the
magnetic actuator.
In the case where all the joints are bent from an angle
varying from 0◦ to ±50◦, the magnetic actuator moves of
a length of 0.325m in the three planes while remaining in
the same positive side. It can be concluded that with small
engine rotations we can reach a large workspace.
(s)
Fig. 8. Torque of the three joints
V. PROTOTYPING
Before designing the real system, a physical prototype has
been realized in order to identify the major characteristics
and the potential pitfalls of the proposed architecture.
A. Motors sizing
The material used for 3D printing prototype is an industrial
thermoplastic PC-ABS. Setting this material to the model of
the robot, designed in Solidworks software, permits to get
the exact characteristics of components. The characteristics
of the manipulator’s bodies are presented in Tab.II.
Body Mass (kg) Characteristics
Arc 1 1.55 Angle extent = 90◦, Major radius = 0.45m
Arc 2 1.25 Angle extent = 90◦, Major radius = 0.40m
Actuator 0.3 Length = 0.012m
Support 4.8 Length = 0.51m
TABLE II
PARAMETERS OF THE MANIPULATOR
After a preliminary study our choice was fixed on electric
actuators. To size the motors, we used ADAMS software
(Automatic Dynamic Analysis of Mechanical System) in
order to define the different torques. The torque of the three
joints during the considered time and trajectories is illustrated
in Fig.8. The most important torque is in the first joint J1,
it has a magnitude of 7.5N.m. For J2 and J3, the torque’s
magnitude is less than 2N.m. These values are so interesting
in the design since the manipulator will be lighter and less
energy-consuming.
Fig. 9. 3D printed prototype
Fig. 10. The five positions of actuation
Characteristic Motor J1 Motor J2 Motor J3
Rated Current (A) 10 3 2
Holding Torque (N.m) 9.8 2.4 2.3
Step Angle (deg) 1.8 0.9 0.9
Length (mm) 126 77 77
Weight (kg) 3.8 1 1
TABLE III
PARAMETERS OF THE MOTORS
Based on these values obtained from dynamic simulations
using ADAMS software, we have chosen the adequate elec-
tric motors for our system. Since the positioning process
is discontinuous, the motors must start and stop frequently.
Stepper motors are well-suited for our application since
they combine high torque and compact design, which in
turn gives them excellent response and acceleration. Fur-
thermore, stepper motors are easy to use in a position
control. Therefore, our choice was fixed on stepper motors
of MOONS company. A Nema 34 Standard Hybrid Stepper
Motor (ML34HD2L4X00) for the first joint J1. A NEMA 23
High Precision Hybrid Stepper Motor (MS23HAAP4300-E)
is chosen for the second joint J2 and for the third joint J3
we have chosen another NEMA 23 High Precision Hybrid
Stepper Motor (MS23HAAP4200). The different parameters
of the three motors are detailed in Tab.III.
B. Experimental validation
To validate the process of magnetic actuator positionning.
The prototype has been realized in ABS-PC using a 3D
printer (see Fig.9). We also realized a head in a human scale
in ABS-PC (in which we planned in advance the locations
of the microscopes and markers) in order to simulate the
effective operating workspace while respecting the different
constraints to guarantee the non collision with the patient.
A laser has been attached to the latter to verify that all
the desired positions (see Tab.I) are attainable. We used an
Arduino Mega for controlling the motions of the manipulator.
For test, we injected the different positions in the system
and we tracked if we are able to pass through all the
regions of the cochlea. Fig.10 shows the different orientations
of the actuator to perform these positions. The results of
the experiments using this manipulator correspond to the
simulation results (with Matlab/SimMechanics) and show its
ability to perform all the needed orientations in order to
reach accurately the different positions. However, our results
suggest that a closed-loop control could enhance the degree
of accuracy and repeatability. Therefore, the prototype needs
further optimization.
VI. CONCLUSION
In this paper we propose a robotic manipulator for the
positioning of a magnetic actuator around the patient’s head.
This actuator is used to guide magnetic particles inside the
cochlea. For this reason and in order to propose an adapted
kinematics, we first studied the anatomical constraints and
the operation of the magnetic actuator. A compact robotic
manipulator is developed to guide a magnetic actuator to
reach all positions required to steer the magnetic particles
inside the cochlea. The next steps consist of optimizing
the realized prototype and controlling the robot using a
closed-loop control system. Accuracy and repeatability of
the robotic arm will then be identified thanks to a Vicon
capture motion.
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